Search Results for: hepatitis C virus

April 5, 2016May 31, 2016

Janssen to Present New Data on Potential Hepatitis B and C Treatments at EASL 2016

News

Janssen Sciences Ireland UC announced it and other Janssen affiliates will present 13 research abstracts, covering ongoing work into potential treatments for the hepatitis B virus (HBV) and potential and approved ones for hepatitis C (HCV), at the International Liver Congress of ... Read more

March 31, 2016March 31, 2016

Merck to Present New Data from Chronic Hepatitis C Clinical Programs at Liver Congress 2016

News

Merck announced its planned presentations of data from its broad clinical development programs for chronic hepatitis C virus (HCV), to be made at the International Liver Congress 2016 taking place in Barcelona, Spain, from April ... Read more

March 24, 2016March 24, 2016

Tailored Approach to Hepatitis C Cure Is More Cost-Effective, According to Study

Hepatitis C, News

Researchers at Loyola University Health System and Loyola University Chicago have determined that costs for hepatitis C virus (HCV) treatment could be cut up to 50 percent if mathematical models are used to ... Read more

March 15, 2016March 15, 2016

Benitec’s Investigational Drug for Hepatitis B Shows Promise in Mouse Model

News

Benitec Biopharma recently announced that a single injection of its investigational drug BB-HB-331, a DNA-directed RNA interference (ddRNAi) therapy targeting the hepatitis B virus (HBV), displays a robust and durable ... Read more

March 10, 2016March 10, 2016

2.3 Million Worldwide Infected with Both Hepatitis C and HIV, Study Reports

News

In a review, London School of Hygiene & Tropical Medicine and University of Bristol researchers found that, worldwide, 2.3 million people with HIV are co-infected with hepatitis C virus (HCV), and more than half of ... Read more

March 8, 2016May 20, 2016

European Committee Gives Initial Nod to Drug Combo to Treat Hepatitis C With Cirrhosis

News

The European Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion for the recommendation of Viekriax plus Exviera, with or without ribavirin, for the treatment of chronic ... Read more

March 1, 2016May 20, 2016

Chronic Hepatitis C Treatment Combo for Genotype 1b Patients Given a Positive Review by CHMP

News

Enanta Pharmaceuticals, Inc., announced that a European Medicines Agency (EMA) panel has given a positive review to the use of Viekirax (ombitasvir/paritaprevir/ritonavir tablets) plus Exviera (dasabuvir) without ribavirin (RBV) for the treatment of chronic ... Read more

February 11, 2016February 11, 2016

High Rates of Hepatitis Infections and Overdoses Seen as Heroin Use Spikes in Connecticut

News

Over the last 20 years drug use in Connecticut’s suburbs has sharply increased and overdoses from opioids and heroin are now at epidemic levels, according to a recent talk by Prof. ... Read more

February 9, 2016February 9, 2016

Exposure to Hepatitis C Is Recurrent Among West African Inhabitants, Who Have Multiple Contacts With HCV

News

West African inhabitants have recurrent occasions for exposure to the hepatitis C virus (HCV), according to the findings of a recent review conducted by a team of Loyola University Medical Center ... Read more

February 4, 2016February 4, 2016

Zepatier, a New Chronic Hepatitis C Treatment, Receives FDA Approval

News

The U.S. Food and Drug Administration (FDA) has approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of adult patients with chronic hepatitis C virus (HCV) genotypes ... Read more